Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Amplification of DNA sequences in human multidrug-resistant KB carcinoma cellsA T Fojo, J Whang-Peng, M M Gottesman, et al.
The Journal of Biological Chemistry|February 5, 1993
Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonistsC E Herzog, M Tsokos, S E Bates, et al.
Biochemistry|July 21, 1992
Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrateS E Bates, S J Currier, M Alvarez, et al.
International Journal of Oncology|February 15, 2001
Wild-type p53 marginally induces endogenous MDR-1 mRNA without causing a measurable drug resistance in human cancer cellsM I Nicoletti, T G Myers, T Fojo, et al.
Journal of Psychiatric Research|September 2, 2017
A precision medicine approach for psychiatric disease based on repeated symptom scoresAnthony T Fojo, Katherine L Musliner, Peter P Zandi, et al.
Archives of Biochemistry and Biophysics|July 1, 1985
Effect of glycerol on protein acetylation by acetic anhydrideA T Fojo, P M Reuben, P L Whitney, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 29, 1998
[Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines]Y Matsumoto, K Morisaki, K Kunishio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administrationZ Zhan, S Scala, A Monks, et al.
Biochemistry|September 7, 1993
Differential modulation of P-glycoprotein transport by protein kinase inhibitionS E Bates, J S Lee, B Dickstein, et al.
Oncogene|June 29, 2000
Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancerP Giannakakou, G Poy, Z Zhan, et al.
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Amplification of DNA sequences in human multidrug-resistant KB carcinoma cellsA T Fojo, J Whang-Peng, M M Gottesman, et al.
The Journal of Biological Chemistry|February 5, 1993
Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonistsC E Herzog, M Tsokos, S E Bates, et al.
Biochemistry|July 21, 1992
Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrateS E Bates, S J Currier, M Alvarez, et al.
International Journal of Oncology|February 15, 2001
Wild-type p53 marginally induces endogenous MDR-1 mRNA without causing a measurable drug resistance in human cancer cellsM I Nicoletti, T G Myers, T Fojo, et al.
Journal of Psychiatric Research|September 2, 2017
A precision medicine approach for psychiatric disease based on repeated symptom scoresAnthony T Fojo, Katherine L Musliner, Peter P Zandi, et al.
Archives of Biochemistry and Biophysics|July 1, 1985
Effect of glycerol on protein acetylation by acetic anhydrideA T Fojo, P M Reuben, P L Whitney, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 29, 1998
[Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines]Y Matsumoto, K Morisaki, K Kunishio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administrationZ Zhan, S Scala, A Monks, et al.
Biochemistry|September 7, 1993
Differential modulation of P-glycoprotein transport by protein kinase inhibitionS E Bates, J S Lee, B Dickstein, et al.
Oncogene|June 29, 2000
Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancerP Giannakakou, G Poy, Z Zhan, et al.
Pageof 18